
SuneKOS is one of the most clinically established injectable skin biostimulator products in European aesthetics, with a strong body of peer-reviewed evidence supporting its efficacy in collagen and elastin stimulation. The technology is based on a patented formulation of hyaluronic acid combined with a specific complex of amino acids — the building blocks of collagen and elastin — that together activate the skin’s own dermal biogenesis process: the natural regenerative mechanism through which the dermis produces new structural proteins.
For the periorbital area, the SuneKOS range includes a specific formulation — SuneKOS Performa — that is developed and clinically validated specifically for the delicate, thin skin around the eyes. Its lower molecular weight hyaluronic acid and targeted amino acid complex are calibrated for this sensitive zone, providing the same collagen and elastin stimulating effect as the standard formulation but in a manner appropriate for the periorbital skin’s unique characteristics.
The result of a course of SuneKOS Eye treatments is a progressive improvement in periorbital skin quality — improved hydration, firmer texture, less prominent fine lines and a fresher, more rested quality to the skin around the eyes — that develops over weeks as the stimulated collagen and elastin production matures within the tissue. Unlike filler, which adds volume, SuneKOS Eye works by improving the intrinsic quality of the skin itself, producing a natural result that does not change the shape or structure of the eye area.
Our Doncaster clinic is on Thorne Road with on-site parking, and we welcome patients from across South Yorkshire including Rotherham, Wakefield, Sheffield, Leeds and Barnsley.
SuneKOS Eye uses the Performa formulation — hyaluronic acid combined with a patented complex of six amino acids (glycine, L-proline, L-leucine, L-lysine, L-valine and L-alanine) — delivered as fine micro-injections to the periorbital skin.
Hyaluronic acid component: The low-molecular-weight hyaluronic acid in SuneKOS Performa provides immediate hydration to the periorbital tissue, attracting and retaining water molecules within the dermis and restoring the plump, supported quality that dehydrated periorbital skin loses. Additionally, hyaluronic acid itself stimulates fibroblast activity at low molecular weights, contributing to the collagen-stimulating effect.
Amino acid complex: The six amino acids provide the specific building blocks that fibroblasts need to synthesise new collagen and elastin fibres. Unlike simple hydration approaches, the amino acid complex actively supplies the substrate for structural protein production — consequently, the skin around the eyes can produce new collagen and elastin more effectively than it could without this targeted supplementation.
The biogenesis response: The combined effect of HA and amino acid delivery activates dermal biogenesis — the process by which the dermis regenerates its own structural matrix. Over the two to four weeks following each injection session, fibroblasts in the periorbital dermis synthesise new collagen type I (the primary structural collagen) and elastin, progressively thickening and strengthening the dermal matrix of the eye area. This improvement is cumulative across a course of four sessions.
Why SuneKOS Performa specifically for the eye area: The standard SuneKOS 200 formulation is used for the face, neck, décolletage and body. The Performa formulation has a different molecular weight profile and amino acid calibration appropriate for the periorbital zone — thinner skin, greater sensitivity and the requirement for a product that will not cause discomfort, swelling or structural change in this delicate area.
The clinical evidence for SuneKOS and amino acid-based biostimulation in collagen synthesis and periorbital skin quality is supported by peer-reviewed research. British Journal of Dermatology — hyaluronic acid and amino acid biostimulation
Before treatment:
During treatment:
After treatment:
The primary purpose of SuneKOS Eye treatment is to restore the intrinsic structural quality of the periorbital skin by activating the dermis’s own collagen and elastin production. By delivering both the stimulus (hyaluronic acid at a biologically active molecular weight) and the substrate (the six amino acids required for structural protein synthesis) directly into the periorbital tissue, SuneKOS Performa enables the skin around the eyes to produce new, structurally sound collagen and elastin in a way that restores thickness, firmness and resilience — addressing the underlying cause of crepey texture and fine periorbital lines rather than masking them.
The collagen and elastin synthesis triggered by each SuneKOS Eye session accumulates across a course of four treatments, with each session deepening the biogenesis response established by the previous one. Maintenance treatments at appropriate intervals following the initial course sustain the improved periorbital skin quality against the ongoing structural decline that ageing continues to produce. Your practitioner will recommend a maintenance interval at the conclusion of your course based on your skin’s response and how the results evolve over time.
The eye area is the focal point of every interaction, and the changes that ageing produces here — the crepey texture, the fine lines, the tired quality that persists regardless of sleep — have a disproportionate impact on how people feel about their overall appearance. Furthermore, these specific changes are among the most resistant to skincare products and surface treatments, because their origin is structural and deep. SuneKOS Eye addresses them at that structural level — producing genuine improvement in the tissue quality that creates the visible change — and consequently the improvement in confidence and how patients feel about their eye area is meaningfully significant.
1. Uses the SuneKOS Performa formulation specifically developed for periorbital use SuneKOS Performa is a clinically validated formulation calibrated for the delicate periorbital skin — not a modification of the standard face product but a dedicated periorbital formulation with its own clinical evidence base.
2. Stimulates genuine collagen type I and elastin production The combination of low-molecular-weight HA and the six-amino-acid complex activates fibroblasts to synthesise new structural collagen and elastin, producing real tissue improvement rather than temporary hydration or volume addition.
3. Provides immediate hydration alongside progressive regeneration The hyaluronic acid component delivers immediate hydration to the periorbital tissue from the first session, providing early visible improvement in skin plumpness and freshness while the longer-term collagen stimulation develops.
4. Improves crepey texture, fine lines and overall periorbital skin quality Progressive dermal thickening and structural improvement reduce the crepey quality and fine lines of the periorbital skin, producing a fresher, firmer and more youthful appearance around the eyes over a course of sessions.
5. Does not add volume or alter the shape of the eye area SuneKOS Eye works by improving the intrinsic quality of the periorbital skin rather than adding volume — consequently, it does not change the shape, structure or expression of the eye area, producing a natural result that looks like healthier skin rather than a treated appearance.
6. Minimal downtime with immediate return to normal activities Most patients return to normal activities immediately or the following day. Mild swelling and possible bruising resolve within a few days to one week.
7. Complements the full eye area treatment range for comprehensive results SuneKOS Eye combines effectively with polynucleotide eye treatment for deeper PDRN-driven regeneration, LaseMD eye treatment for surface resurfacing and tear trough filler for structural volume correction where needed.
Fine Periorbital Lines and Crow’s Feet
The fine lines of the lower lid, the crow’s feet at the outer corners and the general fine line texture of the upper eyelid skin all respond to SuneKOS Eye’s collagen and elastin stimulation. As new structural fibres accumulate in the periorbital dermis over a course of sessions, the skin becomes thicker and more resilient, reducing the depth and prominence of fine periorbital lines progressively.
Crepey Periorbital Skin Texture
Crepey texture — the thin, fragile, tissue-paper quality that periorbital skin develops as collagen density declines — is the concern most directly addressed by SuneKOS Performa’s dermal biogenesis mechanism. The thickening and restoring of the collagen and elastin matrix in the periorbital dermis progressively improves the crepey quality, restoring a smoother, more supported and more plump skin appearance around the eyes.
Dehydrated, Dull Periorbital Skin
The immediate hydration delivered by the HA component of SuneKOS Performa directly addresses periorbital dehydration — restoring the plump, well-hydrated quality that makes the skin around the eyes look fresher and more rested. This immediate effect is apparent from the first session and builds over the course.
Mild Under-Eye Hollowing and Shadowing
While SuneKOS Eye does not add volume in the way that tear trough filler does, the progressive improvement in skin thickness and collagen density can reduce the shadowing and hollow appearance associated with thin, structurally depleted periorbital skin. For patients with both skin quality concerns and structural hollowing, SuneKOS Eye and tear trough filler address these from complementary angles.
General Eye Area Revitalisation
For patients whose primary concern is the overall quality, freshness and vitality of the eye area — rather than a specific fine line or hollowing concern — SuneKOS Eye produces a broad improvement in periorbital skin health that makes the whole eye area look and feel more rested, supported and revitalised.
Both SuneKOS Eye and polynucleotide eye treatment stimulate collagen production in the periorbital tissue and improve eye area skin quality through injectable biostimulation. Understanding their different mechanisms helps clarify which is most appropriate.
SuneKOS Performa provides the substrate for collagen synthesis — delivering hyaluronic acid and the amino acids that fibroblasts need to build new collagen and elastin. The mechanism is nutritive: it supplies what the tissue needs to regenerate itself.
Polynucleotides (PDRN) work at the receptor level — binding to adenosine receptors on fibroblasts to activate cellular regeneration, proliferation and angiogenesis. The mechanism is directive: it tells the cells to regenerate more actively, regardless of substrate availability, and additionally supports new blood vessel formation which is particularly relevant for vascular dark circles.
In practice, the two are frequently complementary rather than competing: SuneKOS Eye for immediate hydration alongside substrate-driven collagen stimulation, polynucleotides for deeper receptor-level activation and vascular improvement. Your practitioner will advise on the most appropriate single or combined approach for your specific periorbital concerns at consultation.
Tear trough filler uses hyaluronic acid dermal filler placed in the tear trough groove to add structural volume and reduce the shadowing and hollow appearance of the under-eye area. Results are immediate and the filler can be dissolved if needed. It is the appropriate choice when structural volume loss is the primary concern and an immediate visible improvement is wanted.
SuneKOS Eye works through biostimulation of the periorbital tissue rather than volume addition — it is more appropriate when the primary concerns are skin quality, crepey texture, fine lines and dehydration rather than structural volume loss.
The two are frequently used together as part of a comprehensive under-eye programme: SuneKOS Eye to improve the quality of the periorbital skin, and tear trough filler to correct structural hollowing where present. Your practitioner will assess which approach, or combination, is most appropriate for your anatomy and goals at consultation.
LaseMD eye treatment uses non-ablative thulium fractional laser to stimulate collagen remodelling and surface renewal in the periorbital skin — addressing fine lines and crepey texture through a laser resurfacing mechanism.
SuneKOS Eye uses injectable biostimulation to supply the substrate for collagen synthesis from below the skin surface — improving tissue quality from within through HA and amino acid delivery.
The two treatments address the periorbital skin from different directions — surface-level laser remodelling and deep tissue substrate delivery — and combine very effectively for patients who want both. SuneKOS Eye can be performed in the weeks between LaseMD eye sessions or as a separate treatment programme addressing complementary aspects of periorbital skin quality.
At Elements Medical, SuneKOS Eye treatment is performed by experienced practitioners using the SuneKOS Performa formulation — the specific product developed and licensed for periorbital use — with technique calibrated for the delicate periorbital zone. Every treatment begins with a thorough consultation to assess your eye area concerns, confirm the appropriate treatment plan and ensure realistic expectations of the results timeline.
SuneKOS Eye is part of our comprehensive eye treatment range at Elements Medical, which also includes polynucleotide eye treatment, LaseMD eye treatment, CO2 eye treatment and tear trough filler. For face and body SuneKOS treatment, see our main SuneKOS treatment page.
Read what our patients say on our Google Reviews page.
20-30 minutes
Improvements can be seen but a course of treatments is recommended for maximum results
Bruising and swelling
Minimal
Immediate / next day
Topical anaesthetic applied 30 min prior to treatment
SuneKOS Eye uses the SuneKOS Performa formulation — a patented blend of low-molecular-weight hyaluronic acid and six essential amino acids — delivered as fine micro-injections to the periorbital skin. The hyaluronic acid provides immediate hydration while the amino acid complex supplies the building blocks for collagen and elastin synthesis, activating the skin’s dermal biogenesis process and progressively improving periorbital skin quality over a course of sessions.
SuneKOS Performa is the specific SuneKOS formulation developed and clinically validated for periorbital use. It differs from the standard SuneKOS 200 formulation used on the face and body in its molecular weight profile and amino acid calibration, making it appropriate for the thin, sensitive periorbital skin. It is the only SuneKOS formulation used for the eye area at Elements Medical.
A course of four sessions at two to three week intervals is recommended for maximum results. The collagen and elastin biogenesis response is cumulative — each session builds on the previous, producing progressively greater improvement in periorbital skin quality across the full course.
The immediate hydration effect from the hyaluronic acid component is noticeable from the first session. Visible improvement in skin quality, texture and firmness typically becomes apparent from two to four weeks after the first session as the collagen stimulation begins to take effect. Maximum results are seen following completion of the full course of four sessions.
The procedure is well-tolerated after topical anaesthetic cream. Most patients describe a mild stinging or pressure sensation during the injections that settles quickly. No injection anaesthetic is required.
Mild swelling and redness in the periorbital area typically resolve within 24 to 48 hours. Bruising can occur — this is more common in the eye area than elsewhere due to the density of small blood vessels — and may take up to one week to fully resolve. Most patients return to normal activities immediately or the following day.
SuneKOS Eye stimulates the skin’s own production of collagen and elastin — it improves the intrinsic quality of the periorbital tissue without adding volume or changing the shape or structure of the eye area. Dermal filler adds hyaluronic acid volume to correct structural hollowing. SuneKOS Eye is more appropriate for skin quality, texture and hydration; tear trough filler is more appropriate for structural volume correction. The two are frequently combined.
Yes. SuneKOS Eye combines well with polynucleotide eye treatment for deeper PDRN-driven tissue regeneration, LaseMD eye for surface resurfacing alongside the injectable biostimulation, and tear trough filler for structural volume correction where needed. Your practitioner will advise on the most appropriate approach at consultation.
No — they use different formulations. The SuneKOS face and body treatment uses SuneKOS 200; the eye treatment uses SuneKOS Performa, which is specifically developed and clinically validated for periorbital use. For face and body SuneKOS treatment, see our SuneKOS treatment page.
SuneKOS Eye treatment is not recommended during pregnancy or breastfeeding.
Please read our disclaimer for more information
Select Your Treatment
Browse through our website and choose the treatment that’s right for you.
Book Online or Call Us
Follow the link below to book your treatment online. Or call us on 01302 34 34 32
Complete Your Forms
Your medical history form will be emailed for you to complete before you attend.
Select Your Treatment
Browse through our website and choose the treatment that’s right for you.
Book Online or Call Us
Follow the link below to book your treatment online. Or call us on 01302 34 34 32
Complete Your Forms
Your medical history form will be emailed for you to complete before you attend.
Call us: 01302 34 34 32
Email us: reception@elements.org.uk
Visit our Instagram
Visit our Facebook
Visit our TikTok
Contact us on WhatsApp